Revenue: The sum of all revenue fields included for a company's operating activities.
Milestone Pharmaceuticals Inc. (MIST) had Revenue of $2.96M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
|
Revenue |
$2.96M |
$-25.80M |
|
$0.33M |
|
$2.64M |
|
$28.02M |
|
$-25.05M |
|
$-0.74M |
|
$-25.80M |
|
$-25.80M |
|
$-25.80M |
|
$-25.80M |
|
$-25.80M |
|
$-25.80M |
|
$-25.05M |
|
$-25.00M |
|
140.91M |
|
140.91M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$161.60M |
|
$0.42M |
|
$1.09M |
|
$162.69M |
|
$25.78M |
|
$60.24M |
|
$143.13M |
|
$168.91M |
|
$-6.22M |
|
$-6.22M |
|
$-6.22M |
|
124.50M |
|
| Cash Flow Statement Financials | |
$-64.01M |
|
$31.96M |
|
$103.48M |
|
$73.05M |
|
$144.47M |
|
$71.43M |
|
$3.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.27 |
|
-- |
|
-- |
|
1.12 |
|
-9.69 |
|
89.03% |
|
-845.49% |
|
-845.49% |
|
-- |
|
-870.60% |
|
-870.60% |
|
$-64.08M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.05 |
|
0.46 |
|
195.55 |
|
414.93% |
|
414.93% |
|
-15.86% |
|
-47.75% |
|
$-0.05 |
|
$-0.45 |
|
$-0.45 |
|